Since Gordon (1960) observed the release of adenosine compound in the blood stream of the ischemic kidney, much interest has been focused on its probable physiological role in the renal circulation. Adenosine and AMP markedly increase renal vascular resistance (Hashimoto et al. 1964 , Hashimoto and Kumakura 1965 , Scott et al. 1965 ), while they are potent vasodilators in other organs. This unique response of renal vasculature to these compounds has stimulated further studies on their possible role in local regulation of the renal blood flow (Harvey 1964 , Thurau 1964 , Nechay 1966 , Haddy and Scott 1968 , Tagawa and Vander 1970 . Recently, Sakai et al. (1968) observed that postocclusive vasoconstriction in the renal artery was potentiated by treatment with dipyridamole, an agent which enhances the effects of adenosine compounds, while it was blocked by phenoxy benzamine. Furthermore, Hashimoto et al. (1970) reported that renal vasoconstri ctor responses to adenosine and also to norepinepbrine were potentiated during intra-arterial infusion of dipyridamole. Daiichi), adenosine-5'-diphosphate trisodium (ADP, Waldhof) (base), adenosine-5'-triphos phate disodium (ATP, Sigma) (base), and dl-norepinephrine hydrochloride (Sandoz) (base). Drugs were dissolved in 0.9% saline as stock solutions and were diluted with 0.9% saline just before use. The drug solutions were injected into the rubber tube close to its con nection with the renal arterial cannula. The volume was fixed at 0.1ml and injected in a period of ten seconds. Control injections of 0.9% saline had no effect on blood flow. For continuous administration, an infusion pump (Harvard Apparatus Model 600-900) was used, adjusted to deliver drug solutions at the rate of 0.1ml per minute.
For the quantitative comparison of vasoconstrictor responses the figure obtained by multiplying the change in blood flow by half its duration was used. The effects of adeno sine, norepinephrine and nerve stimulation during infusion of adenosine compounds are expressed as percentage decreases or increases of the control values.
RESULTS
The rate of renal blood flow Responses to adenosine, norepinephrine and nerve stimulation all recovered promptly to their initial values after cessation of adenosine infusion (Fig. 2) . Dipyridamole is a potent coronary vasodilator but a selective constrictor of the renal artery as are adenosine and AMP. It has been reported to decrease the rate of degradation of adenosine and adenine nucleotides (Koss et al. 1963 , Bunag et al. 1964 ), thus potentiating their actions (Hashimoto et al. 1964 , Stafford 1966 . Recently Sakai et al. (1968) reported that the postocclusive ischemia in the renal artery was potentiated by dipyridamole and blocked by phenoxybenzamine. When postocclusive ischemia was slight, it became marked by alternate treatment with adenosine and norepinephrine. As phenoxybenzamine blocks the vasoconst riction induced by norepinephrine but not that by adenosine, it is suggested that postocclusive vasoconstriction is mainly developed by the renal sympathetic mechanism and that adenosine modulates this through adenosine-norepinephrine interaction. Furthermore, Ono et al. (1966) AMP acted in a manner similar to that of adenosine, but seemed to be a little less effective. AMP also induced vasodilation after recovery from the initial decrease in blood flow by infusion in higher dose (1mg/min). In the potency of inhibiting the response to adenosine, there was statistically no significant differ ence between infusion of adenosine and AMP, but in potentiating the response to norepinephrine, adenosine was more potent and the difference was statistically significant. Decreases in responses to adenosine at various infusion rates of adenosine showed a similar tendency to those by infusion of AMP, ADP and ATP. The differences in these changes are statistically not significant between those caused by infusion of adenosine and AMP (0.05<p), significant between adenosine and ADP or ATP (p<0.05), and not significant for AMP, ADP and ATP. We cannot make any conclusive statement regarding these differences, because adenine nucleotides are partly hydrolyzed to adenosine in the blood. ADP which induced vasoconstriction only in a small dose was less potent in that effect than adenosine or AMP. ATP which induced only vasodilation showed the least effect, although it has been suggested by some authors that it plays a role in the autoregulation of renal blood flow (Harvey 1964 , Scott et al. 1965 , Tagawa and Vander 1970 .
Effects of infusion of AMP
We must consider whether adenosine or AMP plays a physiological role in the local regulation of renal blood flow. At present, there are no data concerning the rate of generation of adenosine and AMP in the renal tissue by change of perfusion pressure. Gordon (1960) found AMP in the renal venous effluent after release of renal artery occlusion, and this is compatible with findings in bioassay studies of renal venous blood during both autoregulation and reactive hyperemia (Scott et al. 1965 ). Furthermore, Gerlach et al. (1963) reported that in complete ischemic kidneys, AMP was decomposed only via IMP, bypassing adenosine. They measured the amount of nucleotides in the renal tissue after ischemia and found no accumulation of adenosine. Thurau (1964) assumed a role of AMP in the autoregulation of renal blood flow from the point of view of nucleotide metabolism. Earlier, Conway and Cooke (1939) reported a relatively high amount of adenosine deaminase in renal tissue. Recently, Weidemann et al. (1969) reported that the major fate of AMP added to the perfusion medium in isolated kidney preparations was dephosphorylation to adenosine by 5'-nucleotidase, while the pathway via IMP was a minor one. Thus, adenosine converted from AMP may play an important role in local regulation of renal blood flow.
